ProKidney Corp Insider Trading

PROK

Last 12 months

Insiders sold $2.95M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Brian Jg Pereira sold $1.88M on Nov 13, 2025, 100% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2024.

Net open-market

−$2.95M

0 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Jun 2024

Jun 13, 2024

Get an email when PROK's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 18 – 20	Brian Jg Pereira Director	SoldNo plan 6 parts	757,164	$1.41 average	$1.07M	77%	Form 4
Nov 12, 2025 – Nov 13, 2025	Brian Jg Pereira Director	SoldNo plan 4 parts	757,162	$2.49 average	$1.88M	100%	Form 4
Jul 8, 2025	Darin J. Weber Chief Regulatory Officer	Sold10b5-1 plan	103,480	$3.02	313K	100%	Form 4
Apr 22, 2025	Control Empresarial De Capitales S.a. De C.v. Large holder	Bought	387,393	$0.71	275K	0.5%	Form 4
Apr 17, 2025	Control Empresarial De Capitales S.a. De C.v. Large holder	Bought	25,000	$0.75	19K	<0.1%	Form 4
Apr 16, 2025	Control Empresarial De Capitales S.a. De C.v. Large holder	Bought	100,000	$0.75	75K	0.1%	Form 4
Apr 14, 2025 – Apr 15, 2025	Control Empresarial De Capitales S.a. De C.v. Large holder	Bought 2 parts	736,105	$0.71 average	523K	1.0%	Form 4
Apr 10, 2025 – Apr 11, 2025	Control Empresarial De Capitales S.a. De C.v. Large holder	Bought 2 parts	1,034,118	$0.61 average	631K	1.4%	Form 4

Aug 18 – 20No plan
Brian Jg Pereira
Director · sold 757,164 at avg $1.41
$1.07M
77% of stake
Nov 12, 2025 – Nov 13, 2025No plan
Brian Jg Pereira
Director · sold 757,162 at avg $2.49
$1.88M
100% of stake
Jul 8, 202510b5-1 plan
Darin J. Weber
Chief Regulatory Officer · sold 103,480 at $3.02
313K
100% of stake
Apr 22, 2025
Control Empresarial De Capitales S.a. De C.v.
Large holder · bought 387,393 at $0.71
275K
0.5% of stake
Apr 17, 2025
Control Empresarial De Capitales S.a. De C.v.
Large holder · bought 25,000 at $0.75
19K
<0.1% of stake
Apr 16, 2025
Control Empresarial De Capitales S.a. De C.v.
Large holder · bought 100,000 at $0.75
75K
0.1% of stake
Apr 14, 2025 – Apr 15, 2025
Control Empresarial De Capitales S.a. De C.v.
Large holder · bought 736,105 at avg $0.71
523K
1.0% of stake
Apr 10, 2025 – Apr 11, 2025
Control Empresarial De Capitales S.a. De C.v.
Large holder · bought 1,034,118 at avg $0.61
631K
1.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PROK, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with PROK

CompareIntrinsic value

IMAImageneBio, Inc.

$4.10+1.99%10

PLURPluri Inc.

$1.23-3.15%30

CRDFCardiff Oncology Inc.

$0.87+1.03%36

PALIPalisade Bio Inc.

$1.25+1.63%20

INBXInhibrx Biosciences, Inc.

$86.76+7.01%15

SCNIScinai Immunotherapeutics Ltd.

$0.45-4.92%30

OTLKOutlook Therapeutics Inc.

$0.46+0.46%10

ZIVOZivo Bioscience Inc.

$8.00+10.34%0

Held by ETFs

PROK is in 5 US ETFs. The largest of them, with PROK's weight in each:

Spot a number that looks wrong? Check it in PROK's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PROK

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.